Clinical and Translational Oncology

, Volume 12, Issue 4, pp 271–277

Evidence in medulloblastomas

Educational Series Multidisciplinary Approach to Cancer Treatment

DOI: 10.1007/s12094-010-0503-y

Cite this article as:
Navajas, A. & Giralt, J. Clin Transl Oncol (2010) 12: 271. doi:10.1007/s12094-010-0503-y

Abstract

Medulloblastoma is the most common infratentorial malignant tumour under 15 years of age. In recent protocols, the patients are stratified for treatment in standard risk or high risk, according to the clinical variables as age, localized or disseminated disease, degree of surgical resection and more recently expected biological behaviour based on retrospective and prospective studies of former samples analyzed. The objectives for future treatments are reduce morbidity without jeopardizing survival.

Keywords

MedulloblastomaSurgeryChemotherapyRadiotherapyEvidencesChildren

Copyright information

© Feseo 2010

Authors and Affiliations

  1. 1.Servicio de Oncología PediátricaHospital de CrucesBaracaldoSpain
  2. 2.Servicio de Oncología RadioterápicaHospital Vall d’HebrónBarcelonaSpain